6.11
9.48%
-0.64
전일 마감가:
$6.75
열려 있는:
$6.6
하루 거래량:
543.07K
시가총액:
$320.96M
수익:
-
순이익/손실:
$-82.44M
주가수익비율:
-2.6798
EPS:
-2.28
순현금흐름:
$-66.75M
1주 성능:
-12.21%
1개월 성능:
+22.69%
6개월 성능:
+243.26%
1년 성능:
+225.00%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617 252 0848
주소
One Main Street, 10th Floor, Cambridge, MA
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-07-14 | 개시 | Piper Sandler | Overweight |
2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2021-09-30 | 개시 | Stifel | Hold |
2021-01-07 | 개시 | Wedbush | Outperform |
2020-11-24 | 개시 | Berenberg | Buy |
2020-05-04 | 개시 | H.C. Wainwright | Buy |
2020-02-24 | 개시 | Canaccord Genuity | Buy |
2020-02-24 | 개시 | Cowen | Outperform |
2020-02-24 | 개시 | JP Morgan | Overweight |
2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?
Zacks Investment Research
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire Inc.
Black Diamond (BDTX) is on the Move, Here's Why the Trend Could be Sustainable
Zacks Investment Research
Does Black Diamond (BDTX) Have the Potential to Rally 152.96% as Wall Street Analysts Expect?
Zacks Investment Research
Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know
Zacks Investment Research
Black Diamond Therapeutics Inc (BDTX) 재무 분석
Black Diamond Therapeutics Inc (BDTX) 순이익 2024
BDTX은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -82.44M 달러로 보고했으며, 전년대비 +9.57% 증가했습니다.
Black Diamond Therapeutics Inc (BDTX) 현금흐름 2024
2023-12-31 종료 분기에 BDTX은 현금흐름(지난 12개월)으로 -66.75M 달러를 기록했으며, 전년 대비 +21.72% 증가했습니다.
Black Diamond Therapeutics Inc (BDTX) 주당 순이익 2024
BDTX이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -1.88달러이며, 전년 대비 +25.40% 성장했습니다.
Black Diamond Therapeutics Inc 주식 (BDTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Behbahani Ali | Director |
Jul 05 '23 |
Buy |
5.00 |
1,000,000 |
5,000,000 |
4,448,757 |
RA CAPITAL MANAGEMENT, L.P. | Director |
Jul 05 '23 |
Buy |
5.00 |
935,850 |
4,679,250 |
3,213,828 |
BIOTECH GROWTH N V | 10% Owner |
Jun 30 '23 |
Buy |
5.00 |
1,000,000 |
5,000,000 |
8,117,839 |
BIOTECH GROWTH N V | 10% Owner |
Jun 27 '23 |
Buy |
5.49 |
1,740,000 |
9,555,036 |
7,117,839 |
Epstein David M. | SEE REMARKS |
Jun 27 '23 |
Sale |
6.70 |
25,000 |
167,500 |
671,423 |
자본화:
|
볼륨(24시간):